QS/1 partners with Therigy to streamline specialty pharmacy operations

Press enter to search
Close search
Open Menu

QS/1 partners with Therigy to streamline specialty pharmacy operations

By Sandra Levy - 08/14/2019
QS/1, a provider of pharmacy operating systems, is partnering with Therigy — a partner in specialty pharmacy software, consulting and outcomes — in an effort to improve specialty pharmacy operations between their dispensing system and therapy management software.

The ability to tap into Therigy will help pharmacies simplify the patient care process to better serve and improve patient outcomes, the company said.

“Therigy is widely known for its patient-centric specialty therapy management technology,” QS/1 director of pharmacy professional affairs Ed Vess said.“This partnership between our two organizations will give QS/1’s pharmacy customers access to cutting-edge services, allowing them to automate, streamline, and focus on patient management.”

Therigy technologies offer a range of resources that give pharmacists the tools required for detailed tracking of patient progress with specialty medications. Combined with QS/1’s NRx pharmacy management system, the interface with Therigy helps pharmacies minimize duplicate data entry and improve workflow by tracking dispenses, managing patient’s care, reporting on outcomes, and running required reports.

“Therigy is excited for this opportunity to team up with QS/1 in this effort,” Therigy CEO Joseph Morse said. “Through this integration, Therigy can electronically receive patient information from QS/1’s systems and automatically populate many of the fields required during the patient onboarding process, giving customers the ability to focus on better care for their patients.”

“Dispensing specialty medications offers revenue potential for community pharmacies,” Vess said, adding, Pharmacists can quickly realize the investment benefits and ultimately increase their profits. We think it is another way community pharmacy can set itself apart from other pharmacy markets that lack that personal touch patients deserve, which has a direct effect on patient adherence.”

RELATED TOPICS